Litcius/Paper detail

Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia

On behalf of the Acute Leukemia Working Party (ALWP) and Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT), Francesca Lorentino, Myriam Labopin, Fabio Ciceri, Luca Vago, Katharina Fleischhauer, Boris V. Afanasyev, Nicolaus Kröger, Jan J. Cornelissen, Montserrat Lovira, Ellen Meijer, Antonı́n Vı́tek, Ahmet Elmaağaclı, Didier Blaise, Annalisa Ruggeri, Christian Chabannon, Arnon Nagler, Mohamad Mohty

2020Leukemia36 citationsDOIOpen Access PDF

Topics & Concepts

TransplantationMedicineInternal medicineHematopoietic stem cell transplantationCyclophosphamideGastroenterologyLeukemiaAcute leukemiaIncidence (geometry)Graft-versus-host diseaseImmunologyHuman leukocyte antigenOncologyChemotherapyAntigenPhysicsOpticsHematopoietic Stem Cell TransplantationImmune Cell Function and InteractionT-cell and B-cell Immunology
Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia | Litcius